Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
manufacturing
Fierce Biotech
FDA snubs Fortress' Zydus-partnered Menkes disease candidate
Sentynl and Cyprium were angling the drug candidate to be the first approved treatment for a rare, often fatal pediatric disease.
Zoey Becker
Oct 1, 2025 12:00pm
Lilly reveals plans for $6.5B API production facility in Texas
Sep 23, 2025 1:00pm
GSK plots $30B investment in US manufacturing, R&D
Sep 16, 2025 7:01pm
Trump's drug tariff reveal still 'weeks away': Reuters
Aug 14, 2025 11:26am
Carbogen boosts ADC production ability with $31M in upgrades
Jun 5, 2025 3:45pm
Ratio inks deal to build radiopharma production facility in Utah
May 13, 2025 10:07am
